Analyzing Sonova (OTCMKTS:SONVY) & Anteris Technologies Global (NASDAQ:AVR)

Sonova (OTCMKTS:SONVY) and Anteris Technologies Global (NASDAQ:AVR) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Profitability

This table compares Sonova and Anteris Technologies Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sonova	N/A	N/A	N/A
Anteris Technologies Global	-4,921.27%	-400.59%	-239.87%

Analyst Ratings

This is a summary of current recommendations for Sonova and Anteris Technologies Global, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonova	2	4	1	1	2.13
Anteris Technologies Global	1	0	1	0	2.00

Anteris Technologies Global has a consensus target price of $15.00, suggesting a potential upside of 130.41%. Given Anteris Technologies Global’s higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Sonova.

Institutional and Insider Ownership

0.0% of Sonova shares are owned by institutional investors. 0.0% of Sonova shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Sonova and Anteris Technologies Global”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonova	$4.36 billion	3.56	$610.01 million	N/A	N/A
Anteris Technologies Global	$1.91 million	140.43	-$76.29 million	($1.81)	-3.60

Sonova has higher revenue and earnings than Anteris Technologies Global.

Volatility and Risk

Sonova has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Anteris Technologies Global has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.

Summary

Sonova beats Anteris Technologies Global on 9 of the 12 factors compared between the two stocks.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.